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Abstract: There is an increasingly growing interest world-wide for the genomics, transcriptomics and proteomics of sa-
liva and the oral cavity, since they provide a non-invasive source of unprecedently rich genetic information. The complex-
ity of oral systems biology goes much beyond the human genome, transcriptome and proteome revealed by oral mucosal 
cells, gingival crevicular fluid, and saliva, and includes the complexity of the oral microbiota, the symbiotic assembly of 
bacterial, fungal and other microbial flora in the oral cavity. In our review we summarize the recent information on oral 
genomics, transcriptomics and proteomics, of both human and microbial origin. We also give an introduction and practical 
advice on sample collection, handling and storage for analysis. Finally, we show the usefulness of salivary and oral ge-
nomics in early diagnosis of cancer, as well as in uncovering other systemic diseases, infections and oral disorders. We 
close the review by highlighting a number of possible exploratory pathways in this emerging, hot research field. 
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INTRODUCTION 
The genomics, transcriptomics and proteomics of saliva 
and the oral cavity became increasingly popular subjects of 
research in recent years, since they represent a non-invasive, 
safe, and cheap source of complex genetic information. The 
source of this information-complexity is the large variety of 
DNAs, RNAs and proteins present in the saliva (Fig. 1). 
Salivary DNAs represent (a) the genetic information (ge-
nome) of the hosting human body, (b) the oral microbes pre-
sent in the mouth (oral microbiota), and (c) the infecting 
DNA-viruses. Salivary mRNAs provide information on the 
transcription rates of host genes (the human oral transcrip-
tome) and those of the oral microbiota. Other salivary RNAs 
may indicate RNA-virus infections. Salivary proteins (pro-
teome) represent both genetic information (i.e. the mass-
spectrometry reveals amino acid sequences, which help to 
elucidate the encoding genes) and help to understand the 
translational regulation of the host body and the oral micro-
biota. This explains the increasing interest on this subject in 
several fields including dentistry, medicine and microbiol-
ogy.  
Many aspects of salivary genomics and proteomics were 
reviewed in recent years. The diagnostic applications of sa-
liva were covered rather extensively [1-4]. Other reviews 
highlighted the possible use of saliva in cancer diagnosis [5- 
8], in the diagnosis of systemic diseases [9], in microbiota 
analysis [10] in proteome analysis [11] in psychobiological 
medicine [12] and in forensic dentistry [13]. However, most  
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of the above reviews discussed a certain specific aspect of 
the field [5-13]. Other summaries either gave a short general 
overview [1, 3, 4, 9], or included many other aspects, which 
are not related to salivary genomics and proteomics (e.g. 
secretory rates, nonpeptide hormones, ionic changes etc.) [2]. 
The aim of the present review is to give an integrative over-
view of salivary genomics, transcriptomics and proteomics 
including the description of saliva collection, handling and 
storage; diagnostic possibilities as well as future perspec-
tives.  
SALIVARY GENOMICS, TRANSCRIPTOMICS AND 
PROTEOMICS: COMPARISON WITH OTHER SAM-
PLE SOURCES 
Cytologic and Biopsic Collection of Samples 
Colpocytology, buccal cell cytology, and several incisial-, 
needle-, and excisial biopsic sample collection methods (etc.) 
are usually used for the analysis of local tissues and organs 
[14-16]. Advantage of such samples is that clear evidence 
may be reached related to the target tissue [16]. The disad-
vantage of such sampling is that such methods (especially 
biopsy methods) are invasive and mostly rather unpleasant 
for the patients. Another disadvantage is exemplified by their 
above-mentioned advantage: they provide a local informa-
tion and are rather unsuitable for the general screening of the 
organism, although it is true that, they also contain the whole 
human genome (DNA) [17]. Cytological and biopsy samples 
are usually sources for detection of local changes related to 
transcriptome (mRNA) and proteome. Such samples are also 
used for verifying infections of the target organ by identify-
ing microbial or viral RNA and DNA [16, 18]. 12    Current Genomics, 2008, Vol. 9, No. 1  Fábián et al. 
Blood and Body Fluid Sampling  
Blood and body fluid sampling such as collection of 
blood and saliva is different. Such samples represent more 
information related to general conditions of the whole body, 
which is advantageous for screening purposes [19]. Disad-
vantage of such sampling is that there is usually no clear 
evidence related to the origin (localization) of the alterations 
detected. Blood sampling also has the disadvantage that it is 
invasive and unpleasant [17]. On the contrary, collection of 
saliva is noninvasive and not unpleasant at all [17]. Blood 
samples contain many mRNAs and proteins from several 
body sources, and blood is a source of human genome (hu-
man DNA), too. Blood may also contain RNAs and DNAs of 
infecting viruses and microbes [20]. Whole saliva is a source 
of both the human and oral microbiotal genome. Saliva is 
also a good tool to detect systemic changes of mRNA and 
proteome because it is blended with contaminating blood, 
gingival crevicular fluid, mucosal transudate and also ul-
trafiltrate of the salivary glands' acini [2] (Fig. 2). Further, 
alterations of oral mucosal cells, salivary glands and oral 
microbiota are also detectable via analysis of salivary mRNA 
and proteome. Finally, saliva contains RNAs and DNAs of 
infecting microbes and viruses of both local tissues (i.e. oral 
mucosal cells, salivary glands) and also tissues located in 
other part of the body [14, 20]. 
Comparison of Blood, Oral Mucosal Cell and Saliva 
Samples 
Regarding to DNA quality blood samples seem to be su-
perior to all other DNA sources, usually all of the samples 
could be genotyped, amplified or sequenced [17]. DNA yield 
from saliva is also rather good in quality, the majority of the 
samples could be genotyped, amplified or sequenced [17, 
21]. Quality of buccal cell DNA seems to be poor [17, 21]. 
Samples of buccal cells collected with swabs were found not 
suitable for genotyping, and could be weakly amplified in a 
comparative study [17]. Buccal cell samples collected with 
foam-tipped applicators (FTA) could be genotyped in the 
majority of the cases, however this kind of sample was not 
suitable for amplification (probably because of the rather 
small DNA-yield) [17]. The above findings are interesting 
all the more, because desquamating mucosal cells are the 
likely source of salivary DNA as well [1]. It might be that 
DNA of spontaneously desquamated cells - present in saliva 
- is more intact than that of artificially removed cells. For 
mRNA analysis all sources including blood [22, 23], mucosal 
cells [24] and saliva [25, 26] can be used effectively. How-
ever, there are some differences related to the origin of 
mRNA present in a certain kind of samples as pointed out 
above. Regarding to protein analysis all the three sources 
may be used, and the protein-yield is good in all cases. How-
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ever, it should be considered that there are proteins of differ-
ent origin present in most of these samples as mentioned 
above. 
GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC 
CONSTITUENTS OF SALIVA 
Genome (Human DNA)  
The value of total DNA content in human whole saliva 
was found in a range between 1.8 – 128.4 μg/mL with a 
mean value of 21.6 μg/mL [17]. In other studies higher val-
ues like 40.3 ± 36.5 μg/mL [27] and 77.5 ± 51.5 μg/mL [21] 
were also reported. A proportion of roughly 70% is of hu-
man origin [27] the other 30% is originated from the oral 
microbiota (and viruses if any). Although it was not jet in-
vestigated in detail, it is likely that desquamated oral mu-
cosal cells represent the main human DNA source of saliva. 
The quality of salivary DNA yield is good, 72% to 96% of 
samples could be genotyped [17, 27], 84% could be ampli-
fied [17] and 67% could be sequenced [17].  
Transcriptome (Human mRNA)  
Although rRNSs and tRNAs are rather stable in the cell, 
mRNAs are usually rapidly degraded (which may happen in 
a few minutes). Partly because of these reasons mRNA con-
stitutes a small proportion of total cellular RNA comparing 
to the much more abundant rRNA and tRNA fractions. Con-
sequently, extracellular RNAs belong mostly to rRNA and 
tRNA fractions, whereas the proportion of mRNA believed 
to be the smallest. It would also be likely that, a high propor-
tion of the salivary RNA is of microbial origin because of 
the rather rich oral microbiota. Based on the above consid-
erations some authors suppose the absence of detectable 
amount of human mRNAs in a cell free saliva [28]. Al-
though this opinion seems to be a bit exaggerated [29] (see 
below), but we would like to point out that caution should be 
used in interpreting saliva-based mRNA expression studies 
without the technical exclusion of possible DNA contamina-
tion artifacts [28, 29].  
The total RNA level in cell free (centrifuged) whole sa-
liva is ranging from 0.108 ± 0.023 μg/mL [25] to 6.6 ± 3.6 
μg/mL [26]. Interestingly, the majority of RNAs present in 
cell free whole saliva is genuine human mRNA  [29]. The 
detectable amount of distinct human mRNA specii is be-
tween 3,000 [25] and 6,400 [26]. These represent roughly 
16% [25] and 13% [26] of the included sequences of applied 
human arrays, respectively, and 28% of the protein-coding 
human genes (calculating with middle value of estimations 
between 20,000 - 25,000 [30, 31]). The proportion of func-
tion-unknown salivary mRNSs is about of 27.5% [32]. There 
are roughly 200 salivary mRNAs found in all the individuals 
termed "normal salivary transcriptome core" (NSCT) [25, 
26, 32, 33]. However, the overlap of individual mRNA 
stocks are usually higher, 419 and 570 identical transcripts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Routes of DNAs, RNAs and proteins of blood origine into the saliva. 14    Current Genomics, 2008, Vol. 9, No. 1  Fábián et al. 
were found in 90% and 80% of the subjects respectively 
[32].  
There is also a comparable amount of RNA in isolated 
parotid saliva (3.6 ± 1.5 μg/mL [26]). However, it contains 
lower number (4,778 transcripts) of informative mRNAs 
than whole saliva does [34]. There are also high number of 
mRNA in sublingual saliva (1,831 transcripts), submandibu-
lar saliva (1,543 transcripts), gingival crevicular fluid (2,689 
transcripts), and desquamated oral epithelial cells (3,142 
transcripts) [34] indicating that, mRNA enters whole saliva 
from various sources [34].  
Microbial DNA and RNA  
There proportion of oral microbiotal DNA is roughly 
32% indicating a significant amount of non-human genome 
in whole not-centrifuged saliva [17]. Although there is no 
concrete data available in the literature about the whole 
amount of non human RNAs in whole not-centrifuged saliva, 
a comparable proportion as in case of DNA is likely. (As 
mentioned above, the majority of RNAs in centrifuged 
whole saliva is of human origin [29] but in this case micro-
biota is removed). 
Salivary Proteome  
The total amount of proteins in whole saliva is ranging 
between 0.5 to 3 mg/mL. This proteome consists of roughly 
1,000 distinct protein sequences [26], from which around 
300 sequences are of human origin [32]. A proportion rang-
ing between 22.8% to 28.7% of detected human sequences 
have an unknown function [32], which is rather similar to the 
proportion of mRNAs with no functional identification [32]. 
The co-existence of a certain protein sequence and its own 
mRNA is detectable in a rather high proportion of proteins 
with exact values ranging between 70% to 93%, which is 
depending on the actual methods used [32]. However, only a 
little correlation of the change of the amount of a certain 
protein and the alterations of its mRNA level were found 
under a particular pathological condition, like the Sjögren's 
syndrome [26]. Latter finding gives an experimental proof of 
our general assumption that both protein and mRNA markers 
are important and provide a non-redundant information [26].  
COLLECTION, HANDLING AND STORAGE OF SA-
LIVA FOR DNA, RNA AND PROTEOME ANALYSIS 
Collection of Saliva 
Whole saliva can be collected by drooling into a vial with 
forward tilted heads, or by allowing the saliva to accumulate 
in the mouth and than expectorate it into a vial [35, 36]. Iso-
lated parotid saliva may be collected with direct cannulation 
of the parotid duct, or with the use of parotid cup (a plastic 
container stabilized on the mucosal surface via a pocket ena-
bling negative pressure). Mixed submandibular/sublingual 
saliva may be collected with direct cannulation of subman-
dibular duct [26]. 
Handling of Saliva 
Since the main source of salivary DNA is given by des-
quamated oral mucosal cells [1], preclearing (i.e. centrifug-
ing, microfiltering) of saliva before DNA analysis is not 
suggested. In contrast, for RNA analysis saliva sample is 
usually centrifuged (i.e. 2,600 x g, 15 min. 4°C [25, 26]), 
because the majority of RNAs present in cell free (centri-
fuged) whole saliva are genuine human mRNAs [29]. How-
ever, the microfiltration of saliva (i.e. instead of centrifug-
ing) is not suggested for RNA analysis, because majority of 
salivary RNA is macromolecule-associated (see also below) 
and will not pass through 0.22 μm or 0.45 μm pore size mi-
crofilters [34]. For RNA studies focusing on oral microbiota, 
any kind of preclearing of saliva should be avoided. For ana-
lyzing salivary proteome of human origin, saliva may be 
precleared by centrifugation (i.e. 10,000 x g; 10 min. 4°C) 
and/or microfiltered by 0.22 μm or 0.45 μm pore size micro- 
filters [35, 36]. However, it should be considered that, high 
molecular weight macromolecule complexes may be sedi-
mented by centrifugation or blocked in pores of microfilters 
leading to certain loss of such complexes (and quick obstruc-
tion of filters). To avoid such loss of macromolecule com-
plexes a lower g-value centrifugation (i.e. 2,600 x g 15 min. 
4°C [25, 26]) may be used, however, in this case microbial 
contamination of the sample is somewhat higher. In case 
that, the proteome of oral microbiota is targeted, all kind of 
preclearing of saliva samples should be avoided. 
DNA Stability 
In appropriate buffers of DNA extraction kits saliva can 
be stored at room temperature for up to at least 1 year [17]. 
However before adding such buffers saliva should be stored 
on ice (+4°C) to prevent bacterial (or other microbial 
growth) and to decrease salivary DNase activity. Saliva can 
also be frozen and stored on -20°C or -80°C before DNA 
extraction [37]. Extracted DNA can be also frozen and stored 
on -20°C or -80°C until use [17].  
RNA Stability  
There are several microbial and/or human RNases pre-
sent in saliva which may destroy RNA molecules, in some 
cases even with a half-lives of a few minutes (range between 
0.4 to 12.2 min.) [34]. Interestingly human salivary mRNAs 
are more stable in saliva than exogenous ones (i.e. mouse 
mRNA added to saliva [34]) indicating that human mRNA is 
protected by certain human-specific mechanisms against 
salivary nucleases [34]. This protective phenomenon likely 
occurs because of RNA-macromolecule interactions [34] and 
can be abolished with detergents [34]. (The phenomenon that 
RNAs associate with other macromolecules is known also in 
serum and plasma. Such complexes are called particle-
associated RNAs [23]). Possible associated proteins of sali-
vary mRNA may be apoptotic bodies of desquamated mu-
cosal cells [22, 34] and several saliva proteins like mucines 
[34]. It may also be hypothesized that, salivary chaperone 
Hsp70  [35, 38] may take part in the protection of human 
mRNA, too. Because of premised possible role of proteins in 
salivary mRNA stability, addition of protease inhibitors to 
salivary samples can be useful even in case of mRNA analy-
sis [25, 26]. Cooling of saliva samples on ice (+4°C) is also 
suggested [25, 26].  
Because of above mechanisms, most of salivary RNAs 
are partially degraded only [29, 34]. On the average salivary 
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[29]. In contrast to blood the degradation pattern is rather 
random with only a slightly more degradation at the 5' end 
(if any) [29, 34]. Further, those of long transcripts have an 
increased chance of being degraded than shorter [29, 34]. 
These findings indicate a predominant endonuclease activity 
in saliva [29, 34] in contrast to blood, in which the activity of 
exonucleases is typical [19]. Because of above, use of RNase 
inhibitors (especially against endonucleases) is recom-
mended to avoid destruction of salivary RNAs. Although 
with the use of certain RNase inhibitors mRNA can be stabi-
lized for longer run even in room temperature [39], however 
cooling of saliva samples on ice (+4°C) is still useful [26]. 
RNA can be preserved in saliva also by freezing at -80°C 
[25], in this case supplementation with stabilizing "RNAlater" 
reagents may be suggested [26].  
Protein Stability 
Precleared saliva can be stored on ice (+4°C) without 
significant protein degradation only for few hours, and with-
out preclearing the degradation is even quicker. Conse-
quently addition of protease inhibitors is advantageous espe-
cially for time consuming analysis procedures. Freezing fre-
quently resulted in significant protein precipitation, even if 
quick freezing is used, and the frozen sample can be stored 
for a few days only without any further damage at -20°C. 
Somewhat longer storage is possible in liquid nitrogen or at -
80°C, however proteins are not stable for a longer run even 
in such conditions.  
SYSTEMS BIOLOGY OF SALIVARY MICROBIOTA 
Complexity of the Oral Microbiota 
The microbiota of the oral cavity consists of more than 
600 microbial specii (or not yet cultivated phylotypes) in-
cluding predominantly bacteria, but also fungi and protozoa 
[40-43], from which 347 clones are predominant in subgin-
gival pocket [43], others are more frequent in the supragin-
gival bacterial biofilm (i.e. dental plaque). However in indi-
vidual hosts just a subset of all specii can be found [44], in-
dicating a high degree of interpersonal variability. The sub-
gingival bacterial community in a single individual was 
found to consist of 25 to 34 [45], 59 [46] or 72 to 99 [43] 
specii and phylotypes in different studies. Similarly, suprag-
ingival tooth-surface attached biofilm (dental plaque) con-
sisted of 11 to 29 [47], or 32 [48], or 52 [49], or up to 94 to 
114 (pooled sample) [50] specii and phylotypes in several 
studies.  
Microbiota of the Saliva  
Despite the important antimicrobial activity of saliva [38, 
51, 52] the complexity of salivary microbiota was similar to 
the oral microbiota above including 37 [40] or 33 to 53 [44] 
different bacterial specii and phylotypes and 1 to 3 yeast 
(Candida) [53] specii, (altogether up to 56 specii and phylo-
types). It is likely that, the total number of salivary specii is 
even higher [44]. To understand the high number of specii 
despite the antimicrobial saliva activity it should be consid-
ered that, the bacterial metabolism alters when certain bacte-
ria get in contact with saliva [54], and several bacteria can 
even ferment and grow on saliva [55]. Further, microorgan-
isms attached to the surfaces of the mouth and teeth are con-
tinuously shed into the salivary fluid, and bacteria residing in 
the periodontal pockets are constantly washed into saliva by 
the gingival crevicular fluid [44]. Because of the above men-
tioned constant microbial replacement, salivary microbiota 
reflect to many changes occurring in any part of the mouth 
as a "fingerprint" of the whole oral microbiota [44, 56]. 
Effect of Salivary Microbiota on other Parts of Gastroin-
testinal Tract 
Increased expression of molecular chaperones (especially 
DnaK) strongly increases the acid tolerance of salivary bac-
teria (i.e. Streptococcus mutans) on pH 5 (or even lower) 
[57]. Such a low pH occur regularly in the deeper area of 
tooth surfaces attached bacterial biofilm (i.e. dental plaque) 
[57] indicating that, many of bacteria present in such biofilm 
may survive in rather low pH. Thus, such bacteria also may 
survive passing through the stomach. This route opens the 
possibility that, oral microbiota may have an influence on 
and alter the microbiota of other parts of gastrointestinal 
tract. For example, Helicobacter pylori bacteria, (a known 
cause of peptic ulcer disease and chronic gastritis) was found 
in higher prevalence in saliva than in feces, indicating that 
oral rout (including oral-oral route like kissing) may be an 
important means of transmission of this infection [58]. Some 
Lactobacillus specii present in the faeces were also found to 
be transient (allochthonous) to the intestine and originate 
from the oral cavity [59]. It is likely that, recently developed 
oral microbiota diagnostic systems based on 16S rRNA mi-
croarrays [10, 60] may lead to recognition of numerous simi-
lar interference of oral and gastrointestinal microbiota. Al-
though the microbiota normally configure to match the usual 
normal community structure, in some cases as-yet uncharac-
terized properties may alter the microbial balance [61, 62]. It 
may not be excluded that, certain transient species of oral 
origin can be responsible for such alterations, leading to sev-
eral pathologic conditions of the gastrointestinal tract.  
SALIVARY DNA, RNA AND PROTEOME IN THE 
DIAGNOSIS OF DISEASES 
Early Cancer Diagnosis  
In case of saliva two major facets of cancer diagnosis 
should be distinguished, such as diagnosis of oral cancers 
(getting direct contact with saliva) and of those in other loca-
tions. Advanced stage oral cancers are usually detectable by 
inspection of the oral cavity. In contrast, early stage oral car-
cinomas are not viewable, frequently not diagnosed or 
treated in time, because even microscopic level for a pro-
gressive cancer can be too late for successful intervention [6, 
63]. Similarly, tumors of other locations are also usually not 
diagnosed early enough, because they are out of sight in 
early stages and also because they are frequently not 
viewable even in advanced stages (depending on location). 
Since the prognosis of advanced stage cancers are much 
worse than of early stage ones, highly sensitive methods for 
both oral and other located early cancer detection are needed 
to reduce lethal outcome of these dangerous diseases [63].  
There are some tumor specific DNA markers in serum 
and other body fluids may be used for the diagnosis of both 
oral and other tumors, based on the assumption that the ini-
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accumulation of specific genetic alterations [1, 6]. In saliva, 
mutated salivary DNA at p53 gene was found in 62.5% of 
oral cancer patients [64]. Similarly, an increased content of 
mitochondrial DNA was found in the saliva (also in tumor 
tissue  [65]) of head and neck cancer patients [66], which 
decreased after the surgical removal of such tumors [67]. 
Detection of HPV (human papilloma virus) DNA in saliva 
also enables the detection of HPV-related head and neck 
cancers [68]. Similarly, detection of DNA (or proviral DNA) 
of other tumor-inducing viruses like HIV (human immu-
nodeficiency virus) [69] and HHV-8 (human herpesvirus 8) 
[70] in saliva may also be useful for oral and/or other located 
cancer risk assessment.  
Analysis of serum mRNAs can also be a good and sensi-
tive tool for detection of certain oral and other tumors [71-
73]. Especially global mRNA-profiling of serum seems to be 
promising [71]. However collection of blood is unpleasant 
for many of subjects [17], it is invasive and expensive to 
some extent. Consequently, the collection of saliva seems to 
be more suitable for the screening of larger populations. Pro-
filing of salivary mRNA indicated four major biomarkers of 
oral cancer including interleukin-1- (IL1), interleukin-8 
(IL8), ornithine decarboxylase antizyme-1 (OAZ1) and 
spermidine/spermine N1-acetyltransferase (SAT). Regres-
sion tree (CART) analysis of these four, elevated biomarkers 
was able to distinguish patients with T1 and T2 oral cancer 
from control subjects with very high sensitivity (91%) and 
specificity (91%) [63]. Beside the above markers, detection 
of tumorigenic virus RNAs, like HIV-1 may also be useful in 
evaluating risk of malignancies [20]. 
Salivary proteome can also be used for tumor detection. 
Increased salivary level of defensin-1 [74], cancer antigen 
CA15-3 [5, 75], tumor marker proteins, like c-erbB-2 [5, 75] 
or CA-125 [76] and antibodies against the tumor suppressor 
protein, p53 [77] seem to be promising markers for both oral 
and other malignancies [2]. A future global proteome profil-
ing of saliva with newly developed methods of proteome 
analysis [78-82] would likely resulted in further candidate 
peptide sequences of sensitive tumor detection [3].  
Other Systemic Conditions 
There are significant changes of salivary proteome and 
transcriptome also in the case of Sjögren's syndrome [26]. A 
recent study indicated 16 down-regulated and 25 up-
regulated distinct amino-acid sequences in whole saliva pro-
teome, from which 10 up-regulated and 6 down-regulated 
proteins seemed to be statistically significant biomarkers of 
Sjögren's syndrome [26]. This study also indicated a higher 
level of total RNA of both whole and parotid cell free saliva 
[26]. In whole saliva 162 mRNAs were up-regulated (at least 
2-fold), whereas only few were down-regulated. 27 mRNAs 
were up-regulated at least 3-fold, and 13 mRNAs were up-
regulated more than 10-fold [26]. From the 27 (at least 3-
fold upregulated) genes 19 were interferon-inducible, or 
were related to lymphocyte infiltration, and antigen presenta-
tion known to be involved in the pathogenesis of Sjögren's 
syndrome. The mRNA of an interferon- inducible protein 
(G1P2) was 500-fold upregulated [26]. Taking together these 
data, it is obvious that the analysis of salivary proteome and 
transcriptome (especially, when used together) provides a 
great possibility for both the better understanding and the 
improved diagnostics of Sjögren's syndrome [26] and other 
diseases.  
Psychological  stress conditions also induce significant 
changes in both salivary proteome and transcriptome. The 
increase of salivary amylase is a known proteomic indicator 
of psychological stress [36, 83] and sympathetic activation 
[84, 85]. A recent paper indicated that amylase specific sali-
vary mRNA level also increases significantly after stress 
with some delay [86]. Besides the above stress-markers, de-
crease of secretory IgA [87], and increase [36] of immune-
modulator defense protein salivary chaperone Hsp70 [35, 38] 
was also reported. Global profiling of genome, transcriptome 
and proteome present in saliva likely lead to the recognition 
of numerous other stress-markers and stress sensitivity 
markers in the next future.  
A number of other disorders exist, where salivary 
changes with significant diagnostic value were also charac-
terized. In Cystic fibrosis the excretion of an unusual, less 
effective form [88] of salivary epidermal growth factor (EGF 
[89]) was reported. There are also characteristic salivary 
changes in case of graft-versus-host disease including the 
elevated concentration of total protein, albumin, EGF, IgG, 
and a decreased amount of IgA and IgM in the saliva [90]. In 
coeliac disease the elevated salivary level of IgA antigliadin 
antibodies (AGA) may be used for screening purposes with 
moderate sensitivity (60%) and high specificity (93%) [91]. 
In case of peptic ulcers and chronic gastritis, Helicobacter 
pylori infection (a frequent cause) can be detected with 84% 
sensitivity and 82% specificity via  detection of bacterial 
DNA in saliva [58]. H. Pylori may also be detected with 
salivary antibodies against this bacterium (sensitivity 85%, 
specificity 55%) [92]. Neurocistercosis can also be identified 
with the detection of antibodies against Taenia solium larvae 
with a sensitivity of roughly 70% [93]. The above mentioned 
disorders and molecular markers may also be taken as exam-
ples of the next future possibilities opening to recognize sen-
sitive diagnostic markers of further disorders [1, 3, 4, 79].  
Virus Infections 
Saliva analysis is a good tool for detection of virus infec-
tions, based on identification of viral DNAs and RNAs, anti-
bodies against viruses, and viral antigens [2, 94]. DNA and 
RNA analysis shows moderate to high sensitivity, however a 
progress related to the accuracy of such methods is very 
likely in the next future. Proteomic methods like detection of 
antibodies against viruses and detection of virus antigens are 
highly sensitive and specific methods available already today 
(see below). Detection of salivary viral DNA is a possible 
diagnostic tool for screening with a moderate to high sensi-
tivity in case of several viruses like cytomegalovirus (sensi-
tivity 36% [14]), human herpes virus (HHV) type 6 (sensitiv-
ity 80% [95]), HHV type 7 (sensitivity 100% [95]), HHV 
type 8 (sensitivity 30% to 66% [18, 70]) and transfusion 
transmitted (TTV [96]) virus (sensitivity 39% [97]). Detec-
tion of salivary proviral DNA (host cell integrated viral se-
quences) may also be used for such purposes with moderate 
sensitivity (40% [98]) in case of human immunodeficiency 
virus type 1 [16, 69, 98]. Detection of viral RNA in saliva 
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tion of viruses like hepatitis G virus (sensitivity 35% to 
100% [97, 99]) and HIV-1 (sensitivity 37% to 100% [14, 20, 
98, 100, 101]). In the proteomic level numerous viruses can 
be detected with high sensitivity and specificity via detection 
of salivary antibodies against viruses. There are highly sen-
sitive methods available for dengue virus (sensitivity 92%, 
specificity 100% [102]), hepatitis A (sensitivity 99%, speci-
ficity 99% [103]), hepatitis B (sensitivity 100%, specificity 
100%  [104]), hepatitis C (sensitivity 100%, specificity 
100%) [104, 105], HIV-1 (sensitivity 95% to 100%, specific-
ity 95% to100% [106-109]), measles (sensitivity 97%, speci-
ficity 100% [110]), mumps (sensitivity 94%, specificity 94% 
[110]), parvovirus type B19 (sensitivity 100%, specificity 
95%  [111]), and rubella (sensitivity 98%, specificity 98% 
[110]). Detection of virus antigens in saliva is also a possible 
highly sensitive and specific method in detection of hepatitis 
B virus (sensitivity 92%, specificity 87% [112]).  
Dental Caries 
There are some more or less specific changes of salivary 
proteome, which may be used for recognizing caries-risk 
patients. These include decreased level of proline-rich pro-
teins (PRP1 and PRP3), histatin 1 and statherin [113]. In-
creased numbers of Streptococcus mutans and Lactobacilli 
in saliva were also associated with increased caries preva-
lence [114, 115], and with the presence of root caries [116]. 
Decreased complexity (fewer number of specii and phylo-
types) of the oral microbiota was also found to be a risk for 
early childhood caries [50]. Although caries related microbi-
otal data were recognized mainly by analysis of tooth-
surface biofilm (dental plaque) but the complex microbiota 
present in saliva [40] likely reflect to this differences as well 
[44, 56]. Investigation of salivary microbiota with high ca-
pacity automatized nucleic acid extraction and analysis [117] 
and also global genome, transcriptome and proteome profil-
ing of saliva will likely lead to further new caries related 
predictive markers in the future.  
Periodontal Inflammation 
The presence of certain periodontopathogen bacterial 
species in saliva reflect their presence in dental plaque and 
periodontal pockets [45, 56, 118, 119] indicating that saliva 
may be a good tool to detect bacterial risk factors by salivary 
DNA analysis of oral microbiota [45]. Such DNA-based 
methods open new perspectives in both the understanding 
and the diagnosis of periodontal disorders, since they allow 
the analysis of non cultivable (yet-to-be cultured) microor-
ganisms as well [45]. Besides genomic methods, proteomic 
analysis may also become important in the next future. It is 
known for example that the level of alpha-2-macroglobulin, 
alpha-1-antitripsin, elastase and also albumin in saliva may 
be good indicators of gingivitis and/or periodontitis. The 
level of salivary defense proteins like immunoglobulin, mo-
lecular chaperone Hsp70, cystatin S, salivary amylase, cal-
protectin, hystatins, lysozyme, lactoferrine, defensins, per-
oxidases, prolin-rich proteins and mucins [38, 51, 52] may 
also have prognostic value related to the possible passing of 
gingivitis to periodontitis (where the latter is a more severe 
inflammation with irreversible destruction) [38, 120, 121]. It 
is also likely that the global profiling of salivary genome, 
transcriptome and proteome will lead to recognition of fur-
ther highly sensitive diagnostic markers of periodontal con-
ditions. 
Oral Candidiasis  
Saliva may also be used for detection of oral fungi [53, 
122]. In case of oral candidiasis, salivary fungal counts may 
also reflect mucosal colonization [123]. Alteration of sali-
vary proteome related to proteins showing antifungal proper-
ties like immunoglobulin, calprotectine, histatin-5, mucins 
peroxidases, basic prolin-rich proteins, molecular chaperone 
Hsp70 etc. [38, 51, 52] may also have important diagnos-
tic/prognostic value especially in recurrent cases.  
CONCLUSIONS AND PERSPECTIVES 
With advances in genomics, transcriptomics and pro-
teomics of saliva, salivary testing in clinical and research 
settings is rapidly proving to be a practical and reliable 
means of recognizing several systemic and oral conditions 
[2, 9]. However, further detailed studies establishing the di-
agnostic value of saliva in comparison with that of other 
biomedia, (especially with blood) will be necessary to assess 
the detailed prognostic and diagnostic value of saliva [4]. At 
this stage of knowledge saliva seems to be a highly impor-
tant possible tool for regular screening of larger populations. 
However, it may also turn out in many cases that saliva is as 
accurate (or even better) as blood in establishing a definitive 
diagnosis of certain disorders and monitoring disease pro-
gression [1, 4]. However, the road to practical and effective 
regular use of salivary diagnostics is expected to be promis-
ing, but long [6, 7]. For the regular clinical use the analysis 
should be highly automatized, and coupled with microfluidic 
technology, enabling a small sample size to be used, avoid-
ing reagents' and waste's cost and allowing that types of as-
says that are impossible at the macroscopic level [10]. The 
identification of biomarkers with a proper and definite sensi-
tivity and specificity to as many disorders and conditions as 
possible is also a prerequisite [7]. Thus, further technological 
advancement and identification of robust and discriminatory 
sets of salivary biomarkers is necessary [7] to fulfill all re-
quirements for being regular diagnostic tool for the everyday 
clinical practice. Despite limitations we experience today, 
the use of saliva for diagnostic purposes becomes increas-
ingly popular, and as a result, more and more diagnostic tests 
become commercially available, and are currently used by 
clinicians and researchers [2]. Taking together all these as-
pects, it can be concluded that there are rich possibilities in 
saliva-diagnostics already at present, and the immediate fu-
ture of this area is even more promising.  
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